You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
STTR Phase I: Silicon nanowire arrays for the sensitive detection and identification of lung cancer by a blood sample
SBC: ADVANCED SILICON GROUP, INC. Topic: SThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is the possibility to revolutionize the treatment of cancer through more sensitive and specific cancer biomarker detection. 1.66 million Americans were diagnosed with cancer in 2014 alone, of which 585,720 died. The sum of all health care costs in 2011 for cancer in the US was $88.7 billion. ...
STTR Phase I 2017 National Science Foundation -
STTR Phase I: Using mining waste as a feedstock for the production of chemicals from CO2 with genetically engineered Acidithiobacillus ferrooxidans
SBC: Ironic Chemicals LLC Topic: BTThe broader impact/commercial potential of this Small Business Technology Transfer (STTR) project is the development of technology for use of sulfide mining waste streams as a novel energy source for the production of chemicals from CO2. Sulfide mining wastes pose a serious, perpetual environmental risk, and are continuously generated as by-products of mining operations. The sulfide minerals in mi ...
STTR Phase I 2017 National Science Foundation -
STTR Phase I: Re-engineered skin bacteria as a novel topical drug delivery system
SBC: Azitra Inc. Topic: BMThis STTR Phase I project aims to establish the viability of a drug delivery platform that employs an engineered strain of Staphylococcus (S.) epidermidis, a common skin commensal bacterium, that can secrete therapeutic proteins of interest for the ultimate goal of treating skin disease. An ointment with an inoculum of such bacteria could be infrequently applied to skin, providing constant, low-co ...
STTR Phase I 2017 National Science Foundation -
Development Characterization and Commercialization of a Viably Frozen Patient Inclusive Hepatocellular Carcinoma Tumor Bank
SBC: Woodland Pharmaceuticals LLC Topic: 103Abstract Hepatocellular carcinoma HCC is a disease of growing incidence globally including in the US by per year With the recent success of anti viral therapies the etiology of HCC in the American population is projected to shift from viral HBV HCV hepatitis to primarily fatty liver disease in the near future Currently only one effective systemic therapy has been developed for HCC ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
SA FasL engineered human islets as a novel product for the treatment of type diabetes
SBC: FasCure Therapeutics LLC Topic: NIDDKPROJECT SUMMARY Type diabetes T D is a chronic autoimmune disorder that affects of population worldwide Exogenous insulin treatment is the standard of care for T D but often negatively affects the quality of life and is ineffective in preventing recurrent hyperglycemia episodes and chronic complications Recent studies show that human islet allografts can restore long term normoglycemia ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of PAR Pepducins as a Novel Antithrombotic Treatment
SBC: OASIS PHARMACEUTICALS, LLC Topic: NHLBICoronary artery disease remains the leading cause of death in the United States Platelets play an important role in the pathogenesis of acute coronary syndrome ACS as platelet activation aggregation and secretion are key components of arterial thrombus formation Despite dual anti platelet therapy for ACS and percutaneous coronary interventions PCI many patients sustain a high incidence u ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
UV emitting nanoparticles as novel radiation sensitizers targeting hypoxic cells
SBC: RADIATION MONITORING DEVICES, INC. Topic: 102Project Summary Abstract Radiation therapy is one of the primary therapeutic techniques for treating cancer Nearly two thirds of all cancer patients will receive radiation therapy during their illness with an average of radiation treatment episodes Although largely effective radiation therapy like other forms of cancer treatment has difficulty killing hypoxic regions within solid tumors ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
STTR Phase I: On-demand optical printing of high-performance personalized eyeglass lenses
SBC: ZENWA,INCORPORATED Topic: MNThis SBIR Phase I project will demonstrate the feasibility of producing ophthalmic lenses utilizing a low cost optical printer that will enable the fabrication of superior quality lenses with a low cost optical printer. The result is development of a business model where an eye exam is administered, prescription lenses are printed and glasses assembled and dispensed in a single visit. Upon complet ...
STTR Phase I 2017 National Science Foundation -
All-Electronic Gamma Rejection Method in Neutron Detection
SBC: NOVA SCIENTIFIC INCORPORATED Topic: 26cNeutron-sensitive microchannel Plates (MCPs) are now providing state-of-the-art user-based, high spatial resolution neutron imaging systems at several US government neutron research facilities as well as university research reactors. Using enriched 10B, thermalized neutron detection efficiencies exceeding 50% have been demonstrated, and cold neutron detection efficiencies of up to 70% have been do ...
STTR Phase I 2017 Department of Energy -
Hardening of the Peridigm Peridynamics Software for Industry Use
SBC: Sunergolab Inc. Topic: 02bExisting research and commercial software that apply the Finite Element Method to solve the equations of classical continuum mechanics have received widespread acceptance for structural analysis of traditional macroscale materials. Challenges persist in the modeling of complex phenomena in new advanced materials with heterogeneous structure. Such materials can revolutionize the aerospace and autom ...
STTR Phase I 2017 Department of Energy